Ms Judy Hemberger

KANDO id: 1601

Bio

Ms Hemberger is based in the US. She is an experienced global pharmaceutical and biotechnology industry executive. She co-founded Pharmion and served as its Executive Vice President and Chief Operating Officer and a director from its inception until 2006. She also worked for 19 years at Marion Laboratories and successor companies Marion Merrell Dow and Hoechst Marion Roussel where she was responsible for leading global regulatory affairs, global medical affairs, and commercial development. Ms Hemberger represents Phase4 Ventures on the board of Chroma Therapeutics and also serves on several other boards including Zymogenetics, Zosano Pharma and Atani.

Career


Nomura Phase4 Ventures Ltd

A global life sciences investor with a focus on development stage healthcare companies

Education